Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort

Overview of attention for article published in Cancer Immunology Research, September 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#11 of 1,611)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 25 news outlets
blogs: 2 blogs
twitter: 13 X users

facebook: 2 Facebook pages
googleplus: 1 Google+ user

Citations

dimensions_citation: 68 Dimensions

Readers on

mendeley: 58 Mendeley

Summary News Blogs X Facebook Google+ Dimensions citations

So far, Altmetric has seen 13 X posts from 13 X users, with an upper bound of 15,746 followers.

Un tipo de inmunoterapia sería de ayuda en la metástasis cerebral Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort https://t.co/XGNT9eK4O6

26 Aug 2018

Reply Repost Favourite

26 Aug 2018

Reply Repost Favourite

Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort https://t.co/f6kXS4N5bD

23 Aug 2018

Reply Repost Favourite

RT @franvilmar: Las nuevas terapias dirigidas demuestran aumentar la supervivencia de pacientes con metástasis cerebrales de #melanoma. #on…

26 Jul 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.